Rosy  Wills

Rosy Wills

Followers 0
Following 0
According to the new market research report Spirometer Market is projected to reach USD 1,285 million by 2025 from USD 799 million in 2020, at a CAGR of 11.1%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18015659The rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition are the key factors driving the growth of this market.The spirometer market has been segmented based on product, mechanism, application, end user and region.Based on product, the spirometer market is segmented into devices, consumables & accessories, and software.This segment is expected to witness the highest growth rate during the forecast period.The rising incidence of respiratory diseases and the growing geriatric population are the key factors driving the growth of this product segment.Based on mechanism, the spirometer market is segmented into flow-sensing spirometer and peak flow meters.The flow- sensing segment accounted for the highest share in 2019.The rising incidence of chronic respiratory diseases and technological advancements are driving the growth of this segment.Based on end user, the Spirometry Market is segmented into hospitals, clinical laboratories, home care settings, and industrial settings.Rapidly growing aging population, the increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced spirometer devices are the factors driving the growth to this market during the forecasted period.
According to research report the Lab Informatics Market is estimated to reach USD 3.8 billion by 2024 from USD 2.6 billion in 2019, at a CAGR of 7.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203037633Growth in this market is mainly driven by the increasing need for laboratory automation, increasing need to comply with regulatory standards, development of integrated lab informatics solutions and the growing demand in biobanks/biorepositories.The pharmaceutical & biotechnology companies segment accounted for the largest share of the life sciences industry market in 2018.The life sciences industry is further segmented into pharmaceutical & biotechnology companies, biobanks & biorepositories, contract service organizations (CROs & CMOs), molecular diagnostics & clinical research laboratories, and academic research institutes.Based on components, the laboratory informatics market is segmented into services and software.The services segment dominated the Lab Informatics Market in 2018.The large share of the services segment can be attributed to the growing technological advancements in solution offerings by various vendors, increasing adoption of cloud-based solutions, growing need for consulting services, and the recurring nature of services.Furthermore, in terms of IT usage and skill, the life science industry relies heavily on service providers.Opportunity: Growing popularity of cloud-based laboratory informaticsThe emergence of cloud-based services via the Internet has led to significant advances in the laboratory informatics market.Advances in virtualization and improved access to high-speed internet offer faster innovation, often at lower costs.
According to the new market research report Clinical Microbiology Market is estimated to be USD 3.9 billion in 2020 and projected to reach USD 5.3 billion by 2025, at a CAGR of 6.5%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367The global microbiological testing market offers significant growth potential for prominent as well as emerging product manufacturers.The clinical microbiology market includes major Tier I and II suppliers like bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland).These suppliers have their manufacturing facilities spread across regions such as North America and Europe.COVID-19 has impacted their businesses as well.Demand for clinical microbiology from key end-users has declined a bit amidst the global COVID-19 pandemic.Industry experts believe that COVID-19 will have a short-term decline in the growth for the clinical microbiology market in 2020, but will experience normal development as the market gradually steadies by the end of 2020.Reagent estimated to be the growing marketThe clinical microbiology reagents market is expected to witness sustained demand during the forecast period, owing to the high prevalence of infectious diseases across major markets (resulting in a growing number of clinical diagnostic procedures), the increasing trend of reagent rental agreements along with instrument sales, and a growing number of life science researches in the field of specific reagents for targeted infectious disease diagnosis and treatment, especially across emerging countries.
SummaryMajor factors influencing the growth of the market.Leading players & Top Segments.Geographic Overview.Market growth influenced due to following factors-Growing cardiovascular and respiratory diseases,Rising adoption of ECMO as a bridge to heart & lung transplantation,Growing number of ECMO centers & conferences and training programs toIncrease awareness, and technological advancements are the significant factors driving the growth of this marketGlobal market size-According to the market research report ECMO machine market is expected to reach $ 305.3 Million by 2021, at a CAGR of 4.3%.These companies together contributed about 68.8% to the global market in 2015.The other players in the market are XENIOS AG (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc. (Germany), and EUROSETS S.r.l.Top Market Segments-Based on the modality, the ECMO machine market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV).The venovenous (VV) segment is estimated to account for the largest share of the global market in 2016, and venoarterial (VA) segment is projected to grow at the highest CAGR in the forecast period.Based on application, the ECMO machine market is segmented into Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation (ECPR).
According to research report wearable healthcare devices market size is projected to reach USD 46.6 billion by 2025 from USD 18.4 billion in 2020, at a CAGR of 20.5% from 2020 to 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973Emerging economies such as China, India and Brazil are expected to provide a wide range of opportunities for players in the market.Furthermore, increasing adoption of AI and 5G, growing adoption of mobile platforms, and the growing awareness and preference for home healthcare will also boost the growth of this market.The major players in the wearable healthcare devices market are Medtronic plc.(Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Biotelemetry Inc.(US), Apple, Inc. (US), Dexcom Inc. (US), Abbott Laboratories(US), CONTEC Medical Systems Co. Ltd (China), Biotricity Inc.(US), Verily Life Sciences.(US), Masimo Corporation(US), GE Healthcare(US), Bio-Beat Technologies (Israel), iRhythm Technologies, Inc. (US), VitalConnect (US), Minttihealth (US), Preventice Solutions, Inc. (US), Cyrcadia Asia Limited (Hong Kong ), ten3T healthcare (India), Fitbit, Inc. (US), Garmin Ltd (Switzerland), Xiaomi Technologies (China), and Huawei Corporation (China).Recent Developments:> In 2019, Apple Watch Series 5 was launched with advanced functionalities by Apple, Inc. (US)> In 2020, Fitbit Charge 4, activity tracker was launched by Fitbit, Inc. (US)> In 2019, Omron (Japan) launched HeartGuide, a wearable blood pressure smart watch.In 2019, the general health and fitness segment accounted for the largest share of the market, primarily due to the increasing focus on physical fitness among people to improve their quality of life, coupled with the growing trend of tracking health progress on a continuous basis.Based on device type, the wearable medical devices market is segmented into diagnostic & monitoring devices and therapeutic devices.In 2019, the diagnostic & monitoring devices segment accounted for a larger share of 64.3% of the wearable medical devices market.
According to the new market research report the Spinal Implants Devices Market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712This market is primarily driven by the launch of advanced bone grafting products, the advancements in spine surgery technologies, increasing incidence of spinal disorders and the increasing adoption of minimally invasive spine surgeries.Based on product, the market is segmented into thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, non-fusion devices, vertebral compression fracture treatment devices, spinal decompression devices, and spine bone stimulators.The thoracic fusion and lumbar fusion devices segment accounted for the largest share of the market in 2019.The large share of this segment can be attributed to the increasing incidence of lumbar degenerative disc disease and the growing number of product launches.Based on the type of surgery, the market is segmented into open and minimally invasive surgeries.The open surgeries segment accounted for the largest share of the Spinal Surgery Devices Market in 2019.The large share of this segment can be attributed to the increasing preference for open spine surgeries among medical professionals, rising incidence of spinal deformities, and technological advancements in spinal fusion surgeries.In addition, some spine procedures, such as spinal implant insertions, can only be done through open surgeries, which is another major factor supporting market growth.On the basis of technology, the Spinal Surgery Devices Market is segmented into spinal fusion and fixation, vertebral compression fracture treatment, motion preservation/non-fusion, and spinal decompression technologies.
According to research report the global MIS Instruments Market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 The major companies in the global minimally invasive surgical instruments market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Smith & Nephew plc (US), Boston Scientific Corporation (US), and CONMED Corporation (US).The advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe are the key factors driving market growth.By type of surgery, the cardiothoracic surgery segment accounted for the largest share of the global MIS instruments market in 2018.The cardiothoracic surgery segment accounted for the largest share of the global MIS devices market in 2018.The large share of this segment can be attributed to the rising prevalence of cardiac diseases, growing awareness about the benefits of early detection of cardiovascular complications, the growing number of coronary and percutaneous cardiology interventions, and increasing adoption of MIS instruments owing to their convenience and better results as compared to other techniques.
According to research report the medical image management market is projected to reach USD 4.40 billion in 2023 from USD 3.04 billion in 2018 at a CAGR of 7.7% during the forecast period.Technological advancements in diagnostic imaging modalities and image management software, growing investments in the medical imaging market, government initiatives to encourage EMR adoption, increasing usage of imaging equipment, growing adoption of image management systems by small hospitals and imaging centers, and rapidly growing big data in healthcare are factors driving the growth of the medical image management system market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240573338Based on procurement model, the enterprise PACS segment is projected to grow at the highest CAGR during the forecast period.By procurement model, the PACS market is segmented into departmental PACS and enterprise PACS.In 2018, the departmental PACS segment is estimated to account for the largest market share.This large share can be attributed to the fact that that PACS were originally designed keeping in mind individual departmental workflows and hence a large number of PACS were adopted in healthcare facilities.The PACS segment is expected to dominate the medical image management market in 2018.Based on product, the medical image management market is segmented into PACS, VNAs, AICA, and enterprise/universal viewers.The PACS segment is expected to account for the largest share of the market in 2018.Factors such as technological advancements in PACS; adoption of PACS in new imaging segments such as endoscopy, ophthalmology, mammography, and oncology; growing adoption of PACS by small hospitals and imaging centers; and government initiatives encouraging healthcare IT adoption are driving the growth of the PACS segment.The hospitals segment is expected to dominate the medical image management system market in 2018.The medical image management market is segmented on the basis of end users into hospitals, diagnostic imaging centers, and other end users including ambulatory surgical centers (ASCs), small clinics, and contract research organizations (CROs).
According to research report the global spinal implants market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712The major players operating in the spinal implants and surgery devices market are Medtronic (Ireland), DePuy Synthes (US), NuVasive, Inc. (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Zimmer Biomet Holdings, Inc. (US), Globus Medical, Inc. (US), Orthofix International N.V. (US), Abbott Laboratories (US), RTI Surgical, Inc. (US), Boston Scientific (US), SeaSpine Holdings Corporation (US), ulrich GmbH & Co. KG (Germany), Spineart (Switzerland), Kuros Biosciences AG (Switzerland), Bioventus, LLC (US), Colfax Corporation (US), Meditech Spine, LLC (US), and Implanet (France).Medtronic (Ireland) dominated the global spinal implants market in 2019, owing to its wide portfolio of spine surgery products and strong geographical presence across the globe.The company primarily focuses on developing technologically advanced products for minimally invasive spine surgeries.DePuy Synthes (US) held the second position in the global spinal implants and surgery devices market in 2019.The company has a strong geographical presence and offers a broad range of products that are integral to the spinal implants and surgical devices market.The company primarily focuses on strengthening its R capabilities to continuously develop and commercialize innovative spine products in the global spinal implants market.Market Growth Factors -Advancements in spine surgery technologies, increasing incidence of spinal disorders, the launch of advanced bone grafting products, and the increasing adoption of minimally invasive spine surgeries are the major factors driving the growth of this segment.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80546246 The Factors such as the rising awareness about oral hygiene, growing incidence of dental diseases, and technological advancements in oral care products are expected to drive the growth of the Oral Care Market.Opportunity: Increasing online purchase of Oral Care Products There has been a noticeable shift in the retailing of oral care products across the world in recent years.Online retailers are slowly being chosen over traditional distributors, retailers, and pharmacies.Buying oral care products through e-commerce portals offers several advantages, such as the accessibility of multi-brand oral care products at comparatively lower prices, ease of purchasing, and free shipping.Challenge: High Dependency on Retail/Consumer Stores Prominent players in the oral care market are highly reliant on on retail stores as they are the direct customers for manufacturers.More Details @ https://www.marketsandmarkets.com/Market-Reports/oral-care-market-80546246.html Recent Developments • In April 2020, GlaxoSmithKline Consumer Healthcare Limited (India) merged with Hindustan Unilever Limited (HUL), with HUL responsible for the distribution of GSK’s Consumer Healthcare brands in India, including its leading oral healthcare brand, Sensodyne.
The growth of the antibacterial susceptibility testing systems market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods.Moreover, rising R investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.According to the new market research report Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984Based on type, the antibacterial susceptibility testing systems segment is expected to account for the largest share of the AST Market in 2019Based on type, the antibacterial susceptibility testing systems market has been segmented into the antibacterial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing, and susceptibility testing types.The major share of the segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements, and the rising burden of antibacterial resistance in developing as well as developed countries.The clinical diagnostics segment is expected to register the highest growth rate during the forecast periodBased on application, the antimicrobial susceptibility testing market has been segmented into the market is segmented into clinical diagnostics, drug discovery and development, epidemiology, and other applications.Significant market growth in the clinical diagnostics segment can be attributed to the rising burden of infectious diseases, the growing burden of antimicrobial resistance, and new product launches in the market.The susceptibility testing disks subsegment of manual antimicrobial susceptibility testing products to hold major market share by 2025Based on the product, the antimicrobial susceptibility testing market is segmented into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables.Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019.The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries.
The growth of the global Hemostasis Analyzer Market is largely driven by the increasing prevalence of cardiovascular diseases and blood disorders, technological advancements in coagulation analyzers, and the rising geriatric population.Emerging economies and growing number of reagent rental agreements are expected to offer growth opportunities to market players in the coming years.According to market research report the global Coagulation Analyzer Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392Optical technology segment accounted for the largest share of the Coagulation Analyzer Market, by technology, in 2019The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology.However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies.The most widely used technology in the Hemostasis Analyzer Market is the optical technology.This segment accounted for the largest share of the market in 2019.Clinical laboratories dominated the Coagulation Analyzer Market in 2019On the basis of end user, the Hemostasis Analyzer Market is segmented into clinical laboratories, hospitals, and other end users.In 2019, the clinical laboratories segment accounted for the largest share of the market.Clinical laboratory analyzers dominated the Coagulation Analyzer Market in 2019Based on product, the Hemostasis Analyzer Market is segmented into clinical laboratory analyzers and point-of-care testing analyzers.
Growth in this market is largely driven by the rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition.According to the new market research report Spirometer Market is expected to reach $1,285 million by 2025 from $799 million in 2020, at a CAGR of 11.1%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18015659The consumables and accessoriessegment accounted for the largest share of the spirometer market, by product segment, in 2019Based on product, the spirometer products market is segmented into devices, consumables & accessories, and software.The consumables and accessories segment accounted for the largest share of the market in 2019.The rising incidence of respiratory diseases and the growing geriatric population are the key factors driving the growth of this product segment.Hospitals segment to register the highest growth rate in the Spirometry Market during the forecast period.Based on end user, the Spirometry Market is segmented into hospitals, clinical laboratories, home care settings, and industrial settings.The hospitals segment is expected to account for the highest share in 2019.Rapidly growing aging population, the increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced spirometer devices are the factors driving the growth to this market during the forecasted period.spirometer products market Opportunity: Emerging economiesEmerging economies such as India, Brazil, China, and South Africa provide significant opportunities for players in the spirometry devices market.Of the top 20 most polluted cities in the world, 14 are in India.The use of spirometers for monitoring lung health is at a very low level in these countries.North America is the largest regional market for spirometer products marketThe global market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW).
Factors such as the rising incidence of lifestyle & cardiovascular diseases and increasing geriatric population are expected to propel the growth of the diagnostic electrocardiograph market.According to the new market research report ECG Market is expected to reach USD 10.3 billion by 2024 from USD 7.5 billion in 2019, at a CAGR of 6.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173The 3-lead ECG segment is expected to grow at the highest CAGR in the diagnostic ECG market during the forecast periodBy lead type, the diagnostic diagnostic electrocardiograph market is divided into 12-lead, 5-lead, 3-lead, 6-lead, single-lead, and other lead types (15- and 18-lead).The 3-lead segment is expected to grow at the highest CAGR during the forecast period.This positive growth is primarily due to the fact that these leads are used conjointly with various other cardiac diagnostic tests and during medical procedures.The hospitals, clinics, and cardiac centers segment accounted for the largest share of the diagnostic electrocardiograph market in 2018By end user, the market is classified into hospitals, clinics, and cardiac centers; ambulatory surgical centers; and other end users.In 2018, the hospitals, clinics, and cardiac centers segment accounted for the largest share of the market.The large share of this segment can primarily be attributed to the growing burden of cardiovascular diseases, which, in turn, is increasing the need for quality cardiology care.Asia Pacific diagnostic diagnostic electrocardiograph market is expected to grow at the highest CAGR during the forecast periodOn the basis of region, the diagnostic ECG market is segmented into North America, Europe, Asia Pacific, and RoW.
According to research report the global contrast media market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911Growth in the contrast agent market can primarily be attributed to factors such as the increasing prevalence of cancer & CVD, regulatory approval of a growing number of contrast agents, and the rising volume of CT & MRI examinations.However, the side effects and allergic reactions associated with contrast agents are expected to limit market growth to a certain extent.The prominent players in the global contrast media market include GE Healthcare (US), Bracco Imaging (Italy), Bayer (Germany), and Guerbet (France) are the major players operating in the market.Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B.Chemicals (India), Sanochemia (Austria), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).By type, the iodinated contrast media segment is expected to account for the largest share of the contrast media market in 2019Based on type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media.In 2019, the iodinated contrast media segment is estimated to account for the largest share of the contrast media industry.The large share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.By modality, the X-ray/CT segment is expected to account for the largest share of the market in 2019Based on modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures.
According to research report the global X-Ray Detectors Market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1% during the forecast period.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7004984Factors such as growing public and private investments in digital imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays are driving the growth of the X-ray detector market.The X-ray detectors market is highly consolidated in nature with several big and emerging players.Prominent players in this market include Varex Imaging Corporation (US), Thales Group (France), Canon, Inc. (Japan), Konica Minolta, Inc. (Japan), Hamamatsu Photonics K.K.(Japan), Teledyne DALSA Inc. (US), Fujifilm Holding Corporation (Japan), Agfa-Gevaert Group (Belgium), Carestream Health (US), Vieworks Co., Ltd (South Korea), Analogic Corporation (US), and Rayence (South Korea).These players have adopted various strategies such as acquisitions, partnerships, collaborations, and product launches to further expand their presence in the global X-ray detectors market.Acquisitions were the key growth strategies adopted by top players such as Varex Imaging Corporation (US), Canon, Inc. (Japan), Konica Minolta, Inc. (Japan), and Agfa-Gevaert Group (Belgium) from 2016 to 2018.The introduction of wireless X-ray detectors, growing medical tourism in developing countries, and the emerging markets are expected to offer significant growth opportunities for market players in the coming years.• Based on applications, the X-ray detectors market is segmented into medical applications, dental applications, security applications, veterinary applications, and industrial applications.The medical applications segment is expected to grow at the highest CAGR during the forecast period.• Based on panel size, the FPDs market is segmented into large-area FPDs and small-area FPDs.
According to research report the Elastography Imaging Market is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 11.0% during the forecast period.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107232051 The major driving factors in the elastography imaging market are growing incidence of breast cancer and chronic liver diseases, and a rising preference for minimally invasive procedures across the globe.The Asia Pacific elastography system market, particularly comprises Asian countries (such as India, China, South Korea, Japan, and Indonesia, among others) and Pacific countries (such as Australia, New Zealand, and Fiji, among others).Emerging Asia Pacific countries, such as India, China, Japan, South Korea, and Indonesia, are witnessing increasing per capita healthcare expenditure and rapid expansion and the modernization of their respective healthcare infrastructure.The hospitals, surgical & diagnostic centers segment, by end user, is projected to occupy the majority of the elastography system market share and grow at the fastest rate during the forecast period.Based on end user, the global elastography imaging market is segmented into hospitals, surgical & diagnostic centers; ambulatory surgical centers; and other end users.
According to research report the digital PCR qPCR market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019.The market is expected to grow at a CAGR of 8.8% from 2019 to 2024.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204 The growth of the digital PCR qPCR market is primarily driven by the rising incidences of target infectious diseases and genetic disorders, increasing financial support for research, and the increasing use of biomarker profiling in disease diagnostics.Companies in the digital PCR market are focusing on novel product development (including lab-on-chip devices, miniaturized devices, and microfluidics-based instruments) to cater to the growing end-user demand for technologically advanced dPCR and qPCR products.North America accounted for the largest share of the digital PCR qPCR market in 2019, followed by Europe.The large share of North American digital PCR qPCR market is mainly due to the rising number of genome-based drug development activities undertaken by US-based pharmaceutical and biotechnology companies, increasing support for the development of dPCR and qPCR technologies, a growing target patient base, and the focus on early and effective disease diagnosis.The global dPCR and qPCR industry offers significant growth potential for current and future players.The digital PCR market is consolidated in nature, with leading players acquiring small market players to gain their state-of-the-art PCR technologies and strengthen their market presence.This also helps them to strengthen their R and distribution network and penetrate markets in emerging nations.
According to market research report Veterinary Dental Equipment Market is projected to reach USD 490 million by 2023 from USD 329 million in 2018, at a CAGR of 8.3% during the forecast period.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155083837Growth in the global companion animal population, the rising incidence of veterinary dental problems, and growth in the number of veterinary practitioners and income levels in developed economies during the forecast period are the primary drivers for the Veterinary Dentistry Equipment Market during the forecast period.North America to dominate the Veterinary Dental Equipment Market in 2018North America is expected to account for the largest share of the Veterinary Dental Instruments Market in 2018, followed by Europe and the Asia Pacific.The growing number of veterinary practices, increasing number of companion animals, and rising companion animal healthcare expenditure are some of the key factors driving the growth of the Veterinary Dentistry Equipment Market in North America.The small companion animals Segment is expected to dominate the Veterinary Dental Instruments Market during the forecast period of 2018 to 2023Based on type of animal, the Veterinary Dental Dentistry Market is segmented into small companion animals and large animals.The small companion animals segment is expected to account for the largest share of the Veterinary Dental Equipment Market in 2018.The large share of this segment can be attributed to the growing companion animal population, increasing pet care expenditure, and the high prevalence of dental diseases in companion animals.The dental equipment segment to account for the largest market share in 2018On the basis of product, the Veterinary Dental Equipment Market is segmented into equipment, hand instruments, consumables, and adjuvants.The dental equipment segment is expected to account for the largest share of the Veterinary Dentistry Equipment Market in 2018.The high cost of dental equipment and the rising income level of veterinarians, resulting in the higher adoption of dental equipment, are major factors responsible for the large share of this segment.Recent Developments -In 2018, Dispomed (US) launched Highdent Quattro Plus, its latest in veterinary dental units.In 2018, Eickemeyer (Germany) signed a partnership agreement with Central CPD (UK) to connect with veterinary practitioners through professional training programs and promote the latest medical equipment.In 2015, Henry Schein (US) acquired Jorgen Kruuse A/S (Denmark) to expand the company's Animal Health business in 23 countries with a strong presence in Nordic countries.Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=155083837The prominent players in the Veterinary Dental Equipment Market are iM3 (Australia), Dentalaire Products International (US), Henry Schein, Inc. (US), Midmark Corporation (US), Dispomed (Canada), MAI Animal Health (US), Integra LifeSciences Corporation (US), Acteon Group (UK), TECHNIK Veterinary Ltd (UK), Cislak manufacturing (US), Eickemeyer (Germany), and J Instruments Inc. (US).
According to the new market research report In Vitro Toxicology Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065The major factors driving the growth of this in vitro toxicity testing market are the opposition to animal testing, technological advancements, and increasing R expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market.Asia Pacific is estimated to be the fastest-growing market for in vitro toxicology testing during the forecast periodThe APAC in vitro toxicology testing market is projected to register the highest growth during the forecast period.Factors such as emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug pipeline, and growing consumer awareness of product safety are some of the key factors driving the growth of the market in the APAC.In the toxicity endpoints and tests market, the organ toxicity segment is expected to grow at the highest CAGR during the forecast periodThe organ toxicity segment is expected to grow at the highest CAGR during the forecast period.The growth in this segment can be attributed to factors such as the increasing focus on drug safety and consumer-product safety, along with the need to screen potential drug targets during the early stage of drug development.Based on the technologies used in the in vitro toxicology testing, the cell culture technologies segment is expected to account for the largest share of the in vitro toxicology testing marketThe cell culture technologies segment is estimated to account for the largest market share in 2018.The large share of this segment can be attributed to the fact that it is the most preferred technique for toxicity testing, being capable of mimicking in vivo conditions.By product and service, the consumables segment is expected to account for the largest share of the in vitro toxicology testing marketThe consumables segment is estimated to account for the largest market share in 2019.The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in vitro toxicology studies.Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209577065The prominent players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).
More

Top